Refractory angina pectoris: mechanism and therapeutic options.
about
Transmyocardial laser revascularization versus medical therapy for refractory anginaEnhanced external counterpulsation for chronic angina pectorisTransmyocardial laser revascularization versus medical therapy for refractory anginaEnhanced external counterpulsation for chronic angina pectorisRecent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.Remodeling an infarcted heart: novel hybrid treatment with transmyocardial revascularization and stem cell therapyPharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary RevascularizationCurrent medical management of chronic stable anginaTreatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation.Enhanced external counterpulsation for refractory angina pectoris.Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.Modulation of cardiac ischemia-sensitive afferent neuron signaling by preemptive C2 spinal cord stimulation: effect on substance P release from rat spinal cord.Enhanced external counter pulsation in treatment of refractory angina pectoris: two year outcome and baseline factors associated with treatment failure.Percutaneous coronary revascularization in patients with formerly "refractory angina pectoris in end-stage coronary artery disease" - not "end-stage" after allClinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging.Chronic stable angina: treatment options.Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarctionMolecular imaging of RNA interference therapy targeting PHD2 for treatment of myocardial ischemia.Engineering and visualization of bacteria for targeting infarcted myocardiumEnhanced External Counterpulsation (EECP): An Evidence-Based Analysis.High prevalence of raised lipoprotein(a) in patients with refractory anginaTreatment of stable angina: medical and invasive therapy--implications for the elderly.Metabolic therapeutics in angina pectoris: history revisited with perhexiline.Short hairpin RNA interference therapy for ischemic heart diseaseC2 spinal cord stimulation induces dynorphin release from rat T4 spinal cord: potential modulation of myocardial ischemia-sensitive neuronsRecurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.Dorsal spinal cord stimulation obtunds the capacity of intrathoracic extracardiac neurons to transduce myocardial ischemia.Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions.Effect of spinal cord stimulation in patients with refractory angina: evidence from observational studies.The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory anginaNoncoronary Collateral Myocardial Blood Flow: The Human Heart's Forgotten Blood Supply.Electrical neuromodulation improves myocardial perfusion and ameliorates refractory angina pectoris in patients with syndrome X: fad or future?Cell Therapy Augments Myocardial Perfusion and Improves Quality of Life in Patients With Refractory Angina.Alternative treatments for angina.Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia.Enhanced external counterpulsation in patients with refractory angina pectoris: a pilot study with six months follow-up regarding physical capacity and health-related quality of life.Obstructive sleep apnoea is associated with myocardial injury in patients with refractory angina.Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study.
P2860
Q24187921-7CE2DB33-2AD4-4A0C-AB5F-EF104C38EF32Q24239959-A7009653-B72D-47E6-BEAD-2DF7D6ED82F8Q24241454-BDC38B5A-4673-47AB-B3F4-9D157C61DA0FQ24242571-EE0ED213-05BF-40FA-948B-F765EB310C68Q24605881-9B02DE82-310A-4415-AFBB-2257FA928295Q26744807-35B4F352-D06B-4B75-8177-4F47050907A0Q28195632-F5ECB6AA-E097-4EDC-8189-A9760BF0E7ADQ28213164-4BE09B62-26FE-4271-8C72-48E56A110F0FQ31112721-F91EDA66-C46A-496A-991C-49D90EB3B764Q31149667-7C3FD60D-A4D3-482A-8118-F0319E4DCCB5Q33151781-77608808-6810-4449-8FCC-73FD1ED6C970Q33305333-0EA12814-1423-4D3B-AF79-5CF8BEB88BB6Q33394364-4C7A9BA9-8D90-4B82-AE45-79977AD09A01Q33498122-55C4E58B-BBB1-4068-9489-6717215A22E5Q33709121-B3C24585-F781-4665-A2E4-A444F5423733Q33815136-782FC801-5107-468A-8C38-F2B8D594918DQ34017342-8CAC2292-5F0E-420C-B70B-37CF2C994BABQ34601238-6B444E8F-5F42-4280-B8D2-69DEDF91CB24Q34994526-11666861-EFF7-489D-8A7A-FFEAFE11A4FEQ36046975-8C2B5072-B2AD-4E8C-9ED0-DB0D8086DD9DQ36187468-260C17DE-9575-4335-A164-79CC9C3994BDQ36193239-4E0B0AC6-70A7-4AED-8974-7F3C6497339FQ36392401-14490233-71B3-436B-A8FC-8DC3D0069E0EQ36853941-F4A4ED59-C5B7-4B66-9C8A-1D8945461EE8Q36977191-273FB7E4-2100-4246-B606-ED70D61D605DQ37140881-A6201A83-330F-4FDC-A989-D93D0718D954Q37298430-C6C75978-7291-41A7-8AA8-F59179B8426FQ37460598-7B7BC4AA-06BB-44BC-8FE3-28800B4E3268Q37987983-FE9D4B00-56A4-42C5-A355-3BE7C883B360Q38233052-2C3D6DB7-6659-4C1A-AAD9-8EF35F49E99DQ38647206-36BC9172-B19C-4EA0-B5EE-73F8342CD36FQ40554077-65D0D581-373F-4243-9275-6162ABAF4980Q42343993-838707C0-F65D-46A5-BF64-CC453A2769ADQ42409590-41790190-3183-45CF-BAEC-5E1C4AF05ACAQ42465823-798D9C5D-9854-4C38-B3CF-7C98E603E946Q44428637-0FF502C6-E916-47BA-B2F9-649A47AB9F63Q47870837-0CA8FC5F-8076-47AC-B9E0-C0B91BAA95A2Q52801424-FCF3AC92-B0ED-4AD2-8A4F-A5551DD11C38
P2860
Refractory angina pectoris: mechanism and therapeutic options.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Refractory angina pectoris: mechanism and therapeutic options.
@ast
Refractory angina pectoris: mechanism and therapeutic options.
@en
type
label
Refractory angina pectoris: mechanism and therapeutic options.
@ast
Refractory angina pectoris: mechanism and therapeutic options.
@en
prefLabel
Refractory angina pectoris: mechanism and therapeutic options.
@ast
Refractory angina pectoris: mechanism and therapeutic options.
@en
P1476
Refractory angina pectoris: mechanism and therapeutic options
@en
P2093
Annapoorna Kini
Michael C Kim
P304
P356
10.1016/S0735-1097(02)01716-3
P407
P577
2002-03-01T00:00:00Z